INTRODUCTION AND OBJECTIVES:
Obesity is a known risk factor for kidney donors to develop chronic kidney disease. The Framingham heart study suggested that visceral adipose tissue (VAT) confers a more adverse metabolic profile compared with subcutaneous adipose tissue (SAT). Asians tend to have a higher VAT composition and it is unclear if their kidney function is affected differently. We hypothesized that living kidney Asian donors who have visceral obesity are at higher risk of renal function deterioration 1 year after donation.
METHODS: Between 2011 and 2014, we retrospectively evaluated data from 73 consecutive patients (52% male; mean age 44.9AE11.7years) before they underwent donor nephrectomy and at their 1 year routine follow up. VAT and SAT were measured at the level of the umbilicus on preoperative computerized tomography (CT). Visceral obesity (VO) was defined as a VAT >100cm 2 and patients were then further examined in 2 subgroups: VAT>100 and <100cm 2 . Estimated glomerular filtration rate (eGFR, mL/min per 1.73m
2 ) was calculated using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation preoperatively and 1 year postoperatively.
RESULTS: Both subgroups demonstrated similar kidney function (P¼NS) preoperatively. At the 1 year follow up, patients with VO experienced a more significant decline of renal function (109AE9 to 89AE8 mL/min per 1.73m 2 ), compared to those without VO (111AE12 to 96AE11 mL/min per 1.73m 2 , P ¼0.013). VO was associated with a body mass index (BMI) >25 kg/m 2 (P <0.001), male gender (P <0.001) and older age at the time of donor nephrectomy (48.0 vs 39.5 years, P ¼0.01). The presence of hypertension or hyperlipidemia preoperatively, choice of surgical approach, and post-operative complication rates, did not differ significantly between the subgroups. CONCLUSIONS: Visceral obesity as defined by VAT >100cm 2 at the level of the umbilicus on cross-sectional imaging, significantly impacts on renal function after donor nephrectomy. We suggest that adiposity markers, as measured by cross-sectional CT imaging, be incorporated into routine pre-operative kidney donor workup.
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MP30-16 LONGER FUNCTIONAL WARM ISCHEMIC TIMES DO NOT IMPACT DONATION AFTER CARDIAC DEATH RENAL ALLOGRAFT OUTCOMES
Heena Singh*, Melissa Huynh, Corinne Weernick, Alp Sener, Patrick Luke, London, Canada INTRODUCTION AND OBJECTIVES: Donation after circulatory death (DCD) renal transplants are associated with long-term outcomes comparable to that of donation after neurological donor death (NDD) transplants, but the effect of longer functional warm ischemia time during withdrawal is unknown. Nevertheless, a hard cutoff of 2 hours warm ischemic time has been used to exclude the use of DCD donors.
METHODS: We retrospectively analyzed the impact of mean arterial pressure (mAp) <55 during donation for different time points (30, 45, 60 , and 90mins) on delayed graft function time (DGF), creatinine clearance (CrCl) at 1 year and overall graft survival. A total of 190 single donations after DCD renal transplants were performed at our institution between July 2006 and June 2016. Outcome variables such as CrCl, hospital stay, readmission rate, DGF and overall graft loss and rejection were compared between groups using the Student t-test and the Pearson chi-square test. A linear regression model was also used for independent prognostication. RESULTS: Mean age of recipients and donors were 54.7 and 44 years old respectively and 13% of the population were expanded criteria donors. Patients were followed for a median of 39 months (range 1 -122 months). The mAp<55 was not associated with DGF (X2¼0.06, p¼0.81), patient death (X2¼0.81, p¼0.34), graft failure (X2¼0.40, p¼0.53), cell mediated (X2¼0.84, p¼0.36) or antibodymediated rejection (X2¼1.25, p¼0.26) of the graft. Independent multivariate regression model looking at mAp<55 as an independent predictor of Cr Cl at 7 days (p¼0.10), 1 month (p¼0.20), 3 month (p¼0.09) or 1 year (p¼0.63) and patient survival (p¼0.82), graft survival (p¼0.17), length of stay (p¼0.35), length of readmission (p¼0.24) did not show any significance. However higher CrCl at 7 days (R2¼0.16, F(3, 105)¼6.99, p <0.05) was an independent predictor of total warm ischemia time.
CONCLUSIONS: The duration of actual and functional warm ischemic time was not associated with DGF, patient death, graft failure or rejection nor for patient or graft survival. The CrCl at 1 week was an Vol. 197, No. 4S, Supplement, Saturday, May 13, 2017 THE JOURNAL OF UROLOGY â e395
